SLDB Solid Biosciences Inc. - Common Stock
$6.31
가격 · 5월 20, 2026
기준 재무 정보 5월 12, 2026
52주 범위
$3–$9
59% of range
애널리스트 평점
BUY
20 analysts
목표 주가
$17
+171% upside
P/E (TTM)
-2.8
ROE
-79.5%
순이익률
—
SLDB 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$6.31
시가총액
$445M
P/E (TTM)
-2.8
EPS (TTM)
$-1.99
매출 (TTM)
—
배당 수익률
—
ROE
-79.5%
부채/자본
—
52주 범위
$3 – $9
SLDB 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
2016-12-31
→
2022-12-31
EPS
$-1.99
2020-12-31
→
2025-12-31
잉여현금흐름
$-157M
2018-12-31
→
2025-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
SLDB
동종업계 중앙값
P/E (TTM)
-2.8
139.1
P/B
2.5
2.4
Price / FCF (주가 / FCF)
-2.8
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
SLDB
동종업계 중앙값
ROA
-82.8%
-36.3%
ROE
-79.5%
-51.4%
ROIC
-99.6%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
SLDB
동종업계 중앙값
Current Ratio (유동비율)
6.1
6.1
Quick Ratio (당좌 비율)
1.8
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
SLDB
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
SLDB
동종업계 중앙값
SLDB 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
20 명의 애널리스트
- 적극 매수 8 40.0%
- 매수 11 55.0%
- 보유 1 5.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
13 명의 애널리스트 · 2026-05-18
중앙값
$16.00
← 모든 목표가 하회
$6.31
저가
$12.00
고가
$26.00
중앙값 목표
$16.00
+153.6%
평균 목표
$17.08
+170.6%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.04%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.52 | $-0.44 | -0.08% |
| 2025년 12월 31일 | $-0.53 | $-0.53 | -0.00% |
| 2025년 9월 30일 | $-0.48 | $-0.45 | -0.03% |
| 2025년 6월 30일 | $-0.42 | $-0.51 | 0.09% |
| 2025년 3월 31일 | $-0.59 | $-0.57 | -0.02% |
| 2024년 12월 31일 | $-1.00 | $-0.82 | -0.18% |
동료 비교 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| DSGN | $567M | -7.7 | — | — | -32.8% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| EIKN | — | — | — | — | — | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| TRAX | — | — | — | — | — | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $8M | $14M | $0 | $0 | $0 | $0 | |
| R&D Expense | $140M | $96M | $77M | $78M | $59M | $65M | $95M | $58M | $40M | |
| SG&A Expense | $39M | $33M | $28M | $29M | $27M | $22M | $25M | $18M | $15M | |
| Operating Expenses | $179M | $130M | $104M | $115M | $86M | $88M | $119M | $76M | $55M | |
| Operating Income | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | $-119M | $-76M | $-55M | |
| Interest Income | $10M | $9M | $8M | $3M | $64.0K | $115.0K | $2M | $619.0K | $219.0K | |
| Other Non-op | $824.0K | $652.0K | $1M | $-381.0K | $2.0K | $1.0K | $515.0K | $270.0K | $1M | |
| Pretax Income | $-174M | $-125M | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| EPS (Basic) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| EPS (Diluted) | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 | $-25.50 | · | · | · | |
| Shares (Basic) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| Shares (Diluted) | 87,504,631 | 40,816,694 | 19,884,007 | 8,512,089 | 7,118,024 | 3,462,475 | · | · | · | |
| EBITDA | $-179M | $-130M | $-104M | $-106M | $-72M | $-88M | · | $-76M | · |
대차대조표 21
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $80M | $74M | $155M | $119M | $155M | $76M | $86M | $52M | |
| Short-term Investments | · | · | · | · | · | · | · | $36M | $17M | |
| Prepaid Expense | $16M | $8M | $6M | $6M | $15M | $4M | $3M | $6M | $1M | |
| Current Assets | $205M | $157M | $130M | $220M | $223M | $159M | $86M | $129M | $71M | |
| PP&E (Net) | $4M | $5M | $7M | $10M | $6M | $8M | $12M | $10M | $2M | |
| PP&E (Gross) | $18M | $18M | $19M | $21M | $18M | $17M | $16M | $12M | $3M | |
| Accum. Depreciation | $14M | $13M | $13M | $11M | $12M | $9M | $5M | $2M | $504.0K | |
| Other Non-current Assets | $223.0K | $366.0K | $209.0K | $175.0K | $94.0K | $209.0K | $209.0K | $209.0K | · | |
| Total Assets | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Accounts Payable | $3M | $4M | $2M | $3M | $4M | $3M | $7M | $4M | $5M | |
| Accrued Liabilities | $19M | $20M | $10M | $17M | $10M | $9M | $9M | $8M | $6M | |
| Current Liabilities | $33M | $30M | $15M | $23M | $24M | $24M | $18M | $12M | $11M | |
| Capital Leases | $19M | $21M | $23M | $24M | $275.0K | $2M | $4M | $859.0K | · | |
| Other Non-current Liabilities | · | · | · | $96.0K | · | $1M | · | $1M | · | |
| Total Liabilities | $53M | $51M | $38M | $49M | $24M | $39M | $23M | $14M | $11M | |
| Common Stock | $79.0K | $40.0K | $20.0K | $20.0K | $7.0K | $87.0K | $48.0K | $35.0K | · | |
| Retained Earnings | $-958M | $-783M | $-659M | $-563M | $-477M | $-405M | $-316M | $-199M | $-124M | |
| AOCI | $52.0K | $47.0K | $15.0K | $-68.0K | $-45.0K | $0 | $1.0K | $-5.0K | $-13.0K | |
| Stockholders' Equity | $180M | $137M | $126M | $212M | $208M | $132M | $80M | $125M | $-59M | |
| Liabilities + Equity | $233M | $189M | $165M | $260M | $232M | $171M | $103M | $140M | $76M | |
| Shares Outstanding | 78,967,888 | 40,468,141 | 20,386,606 | 19,556,732 | 7,356,017 | 84,893,994 | 45,987,571 | 35,432,460 | 0 |
현금 흐름 11
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $2M | $3M | $4M | $3M | · | · | |
| Stock-based Comp | $17M | $11M | $8M | $8M | $13M | $12M | $14M | $6M | $5M | |
| Restructuring | · | · | $-63.0K | $7M | · | $2M | · | · | · | |
| Operating Cash Flow | $-156M | $-100M | $-94M | $-98M | $-78M | $-57M | $-93M | $-70M | $-43M | |
| CapEx | $1M | $654.0K | $2M | $3M | $1M | $899.0K | $4M | $8M | $2M | |
| Investing Cash Flow | $-58M | $-16M | $10M | $59M | $-91M | $7M | $25M | $-27M | $10M | |
| Stock Issued | · | · | $3M | $73M | $135M | $113M | $49M | · | · | |
| Net Stock Activity | · | · | $3M | $73M | $135M | $113M | · | · | · | |
| Financing Cash Flow | $194M | $122M | $3M | $75M | $135M | $129M | $58M | $132M | $77M | |
| Net Change in Cash | $-20M | $6M | $-81M | $36M | $-34M | $79M | $-10M | $35M | $44M | |
| Free Cash Flow | $-157M | $-101M | $-96M | $-101M | $-79M | $-57M | · | $-78M | · |
수익성 6
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| Net Margin | · | · | · | -1062.3% | -530.0% | · | · | · | · | |
| EBITDA Margin | · | · | · | -1315.2% | -530.5% | · | · | · | · | |
| ROA | -82.8% | -70.5% | -45.2% | -34.9% | -35.8% | -64.3% | · | -69.3% | · | |
| ROE | -79.5% | -82.0% | -70.9% | -48.4% | -33.5% | -114.4% | · | -55.4% | · | |
| ROIC | -99.6% | · | · | · | · | · | · | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 | 6.5 | · | 10.3 | · | |
| Quick Ratio | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 | 6.3 | · | 6.9 | · |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.0 | · | 0.0 | · |
성장률 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -40.6% | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $8M | $14M | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-174M | $-125M | $-96M | $-86M | $-72M | $-88M | $-117M | $-75M | $-52M | |
| Market Cap | $445M | $162M | $125M | $105M | $2.90B | $9.65B | · | $14.24B | · | |
| P/E | -2.8 | -1.3 | -1.3 | -0.5 | -2.6 | -4.5 | · | · | · | |
| P/S | · | · | · | 13.0 | 212.7 | · | · | · | · | |
| P/B | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | 113.8 | · | |
| P / Tangible Book | 2.5 | 1.2 | 1.0 | 0.5 | 13.9 | 73.1 | · | · | · | |
| P / Cash Flow | -2.8 | -1.6 | -1.3 | -1.1 | -37.2 | -170.5 | · | -202.9 | · | |
| P / FCF | -2.8 | -1.6 | -1.3 | -1.0 | -36.6 | -167.9 | · | -182.7 | · | |
| Earnings Yield | -35.3% | -76.5% | -78.7% | -187.7% | -38.6% | -22.4% | · | · | · |
손익계산서 14
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $46M | $38M | $39M | $32M | $31M | $31M | $27M | $19M | $19M | $15M | $17M | $20M | $25M | $21M | $14M | $23M | |
| SG&A Expense | $11M | $11M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $7M | $6M | $7M | $7M | $8M | $7M | $7M | |
| Operating Expenses | $57M | $49M | $48M | $42M | $40M | $40M | $35M | $28M | $27M | $22M | $23M | $27M | $32M | $35M | $21M | $32M | |
| Operating Income | $-57M | $-49M | $-48M | $-42M | $-40M | $-40M | $-35M | $-28M | $-27M | $-22M | $-23M | $-27M | $-32M | $-35M | $-21M | $-25M | |
| Interest Expense | · | · | · | · | · | · | · | $88.0K | $95.0K | · | · | $111.0K | $121.0K | · | · | · | |
| Interest Income | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $735.0K | $293.0K | |
| Other Non-op | $157.0K | $219.0K | $210.0K | $207.0K | $188.0K | $199.0K | $211.0K | $239.0K | $3.0K | $270.0K | $278.0K | $265.0K | $282.0K | $-355.0K | $-13.0K | $-3.0K | |
| Income Tax | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-57M | $-50M | $-46M | $-39M | $-39M | $-43M | $-33M | $-25M | $-24M | $-20M | $-21M | $-25M | $-30M | $-15M | $-20M | $-25M | |
| EPS (Basic) | $-0.52 | $-0.50 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | $-3.33 | |
| EPS (Diluted) | $-0.52 | $-0.67 | $-0.48 | $-0.42 | $-0.59 | $-1.02 | $-0.79 | $-0.61 | $-0.64 | $-0.99 | $-1.05 | $-1.25 | $-1.54 | $-0.69 | $-2.71 | $-3.33 | |
| Shares (Basic) | 109,811,461 | -167,394,706 | 94,417,746 | 94,140,286 | 66,341,305 | -79,716,357 | 41,443,317 | 40,934,361 | 38,155,373 | -39,406,941 | 20,059,641 | 19,663,672 | 19,567,635 | -14,051,736 | 7,532,706 | 7,523,964 | |
| Shares (Diluted) | 109,811,461 | -167,394,706 | 94,417,746 | 94,140,286 | 66,341,305 | -79,716,357 | 41,443,317 | 40,934,361 | 38,155,373 | -39,406,941 | 20,059,641 | 19,663,672 | 19,567,635 | -14,051,736 | 7,532,706 | 7,523,964 | |
| EBITDA | $-57M | · | $-48M | $-42M | $-40M | · | $-35M | $-28M | $-27M | · | $-23M | $-27M | $-32M | · | $-21M | $-25M |
대차대조표 20
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $297M | $60M | $61M | $139M | $211M | $80M | $64M | $96M | $118M | $74M | $49M | $92M | $165M | $155M | $49M | $54M | |
| Prepaid Expense | $15M | $16M | $9M | $11M | $6M | $8M | $8M | $7M | $8M | $6M | $5M | $7M | $5M | $6M | $5M | $7M | |
| Current Assets | $397M | $205M | $245M | $279M | $313M | $157M | $179M | $198M | $214M | $130M | $148M | $167M | $191M | $220M | $148M | $170M | |
| PP&E (Net) | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $9M | $10M | $6M | $7M | |
| PP&E (Gross) | · | $18M | · | · | · | $18M | · | · | $19M | $19M | $19M | $19M | $19M | $21M | $16M | $20M | |
| Accum. Depreciation | · | $14M | · | · | · | $13M | · | · | $13M | $13M | $12M | $12M | $11M | $11M | $9M | $13M | |
| Other Non-current Assets | $183.0K | $223.0K | $247.0K | $278.0K | $319.0K | $366.0K | $475.0K | $515.0K | $175.0K | $209.0K | $315.0K | $181.0K | $238.0K | $175.0K | $422.0K | $438.0K | |
| Total Assets | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | $208M | |
| Accounts Payable | $6M | $3M | $8M | $5M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $3M | $6M | $3M | $5M | $5M | |
| Accrued Liabilities | $19M | $19M | $19M | $17M | $15M | $20M | $13M | $10M | $10M | $10M | $11M | $11M | $12M | $17M | $10M | $16M | |
| Current Liabilities | $30M | $33M | $36M | $30M | $29M | $30M | $23M | $15M | $14M | $15M | $16M | $16M | $20M | $23M | $17M | $22M | |
| Capital Leases | $18M | $19M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $23M | $24M | $24M | $24M | $24M | $25M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | $96.0K | · | · | |
| Total Liabilities | $49M | $53M | $56M | $50M | $49M | $51M | $45M | $38M | $38M | $38M | $40M | $41M | $46M | $49M | $41M | $46M | |
| Common Stock | $98.0K | $79.0K | $78.0K | $78.0K | $77.0K | $40.0K | $39.0K | $39.0K | $38.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $8.0K | $112.0K | |
| Retained Earnings | $-1.01B | $-958M | $-908M | $-862M | $-823M | $-783M | $-741M | $-708M | $-683M | $-659M | $-638M | $-617M | $-593M | $-563M | $-548M | $-527M | |
| AOCI | $-13.0K | $52.0K | $48.0K | $-38.0K | $2.0K | $47.0K | $116.0K | $-15.0K | $-4.0K | $15.0K | $2.0K | $14.0K | $5.0K | $-68.0K | $-196.0K | $-122.0K | |
| Stockholders' Equity | $374M | $180M | $218M | $258M | $294M | $137M | $167M | $193M | $211M | $126M | $144M | $164M | $184M | $212M | $143M | $162M | |
| Liabilities + Equity | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M | $249M | $165M | $185M | $205M | $230M | $260M | $184M | $208M | |
| Shares Outstanding | 98,394,720 | 78,967,888 | 77,882,685 | 77,602,741 | 77,492,959 | 40,468,141 | 38,930,203 | 38,551,059 | 37,833,689 | 20,386,606 | 20,061,751 | 20,044,389 | 19,573,132 | 19,556,732 | 7,533,081 | 112,964,698 |
현금 흐름 10
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $395.0K | $467.0K | $376.0K | $386.0K | $407.0K | $488.0K | $405.0K | $1M | $327.0K | · | · | · | · | · | · | · | |
| Stock-based Comp | $5M | $6M | $4M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $0 | $-63.0K | · | $6M | $0 | $2M | |
| Operating Cash Flow | $-47M | $-54M | $-33M | $-37M | $-32M | $-30M | $-24M | $-21M | $-25M | $-21M | $-18M | $-27M | $-28M | $-34M | $-20M | $-16M | |
| CapEx | $165.0K | $565.0K | $85.0K | $377.0K | $126.0K | $204.0K | $15.0K | $286.0K | $149.0K | $90.0K | $383.0K | $536.0K | $506.0K | $856.0K | $839.0K | $1M | |
| Investing Cash Flow | $45M | $47M | $-45M | $-33M | $-27M | $39M | $-11M | $-5M | $-38M | $45M | $-25M | $-48M | $37M | $66M | $15M | $-60M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $239M | $5M | $1M | $-2M | $190M | $7M | $3M | $5M | $107M | $505.0K | $0 | · | · | $75M | $-1.0K | $73.0K | |
| Net Change in Cash | $237M | $-1M | $-78M | $-72M | $130M | $16M | $-31M | $-22M | $44M | $25M | $-43M | $-73M | $9M | $106M | $-6M | $-75M | |
| Free Cash Flow | $-47M | · | · | · | $-32M | · | · | · | $-25M | · | · | · | $-29M | · | · | · |
수익성 2
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.8% | · | -18.9% | -14.6% | -13.3% | · | -16.5% | -11.5% | -10.2% | · | -11.4% | -11.9% | -13.8% | · | -9.4% | -10.6% | |
| ROE | -17.0% | · | -23.8% | -17.5% | -15.6% | · | -21.0% | -14.1% | -12.3% | · | -14.6% | -15.1% | -16.3% | · | -11.1% | -12.5% |
유동성 및 지급능력 3
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.1 | · | 6.7 | 9.3 | 10.9 | · | 7.9 | 13.5 | 14.9 | · | 9.4 | 10.6 | 9.4 | · | 8.7 | 7.8 | |
| Quick Ratio | 9.8 | · | 1.7 | 4.7 | 7.3 | · | 2.8 | 6.5 | 8.2 | · | 3.1 | 5.8 | 8.1 | · | 2.9 | 2.5 | |
| Interest Coverage | · | · | · | · | · | · | · | -315.8 | -282.8 | · | · | · | · | · | · | · |
가치 평가 (TTM) 9
| 지표 | 추세 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | |
| Net Income TTM | $-181M | · | $-157M | $-137M | $-121M | · | $-103M | $-95M | $-100M | · | $-96M | $-100M | $-101M | · | $-89M | $-87M | |
| Market Cap | $708M | · | $481M | $378M | $287M | · | $271M | $219M | $504M | · | $51M | $105M | $93M | · | $53M | $1.04B | |
| P/E | -3.6 | · | -2.9 | -2.2 | -1.5 | · | -2.3 | -1.6 | -3.0 | · | -0.4 | -0.6 | -0.4 | · | -0.6 | -1.0 | |
| P/B | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | 6.4 | |
| P / Tangible Book | 1.9 | · | 2.2 | 1.5 | 1.0 | · | 1.6 | 1.1 | 2.4 | · | 0.4 | 0.6 | 0.5 | · | 0.4 | 6.4 | |
| P / Cash Flow | -15.0 | · | · | · | -9.0 | · | · | · | -20.0 | · | · | · | -3.3 | · | · | · | |
| P / FCF | -14.9 | · | · | · | -9.0 | · | · | · | -19.9 | · | · | · | -3.3 | · | · | · | |
| Earnings Yield | -27.9% | · | -34.2% | -46.0% | -66.5% | · | -44.3% | -62.6% | -33.6% | · | -259.9% | -168.5% | -231.0% | · | -168.6% | -100.3% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | — | — | — | $8M | $14M |
| 영업이익률 % | — | — | — | -1315.2% | -530.5% |
| 순이익 | $-174M | $-125M | $-96M | $-86M | $-72M |
| 희석 EPS | $-1.99 | $-3.06 | $-4.83 | $-10.10 | $-10.14 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 6.1 | 5.2 | 8.9 | 9.8 | 9.4 |
| 당좌 비율 | 1.8 | 2.7 | 5.1 | 6.9 | 5.0 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-157M | $-101M | $-96M | $-101M | $-79M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.